Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27281765 | 0.86 | NLRP3 (0.45) | NLRP3ALDH1A1GAAL3MBTL1MAPT | |
| SCHEMBL8835734 | 0.80 | ALDH1A1 (0.49) | NLRP3ALDH1A1GAAL3MBTL1MAPT | |
| SCHEMBL24193415 | 0.76 | ALDH1A1 (0.45) | NLRP3ALDH1A1GAAL3MBTL1MAPT | |
| SCHEMBL4773221 | 0.72 | TSHR (0.44) | ALDH1A1GAAL3MBTL1KDM4ETDP1 | |
| SCHEMBL11162092 | 0.72 | KDM4E (0.42) | NLRP3ALDH1A1GAAL3MBTL1KDM4E | |
| SCHEMBL18055614 | 0.71 | TDP1 (0.53) | ALDH1A1GAAMAPTKDM4ETDP1 | |
| SCHEMBL7219075 | 0.71 | NLRP3 (0.55) | NLRP3ALDH1A1GAAL3MBTL1MAPT | |
| SCHEMBL10712041 | 0.71 | ALDH1A1 (0.40) | NLRP3ALDH1A1GAAL3MBTL1TDP1 | |
| SCHEMBL120324 | 0.70 | TSHR (0.67) | NLRP3ALDH1A1GAAL3MBTL1MAPT | |
| SCHEMBL28752423 | 0.70 | ALDH1A1 (0.42) | NLRP3ALDH1A1GAAL3MBTL1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015088565-A1 | P2X4 RECEPTOR MODULATING COMPOUNDS AND METHODS OF USE THEREOF | SUNOVION PHARMACEUTICALS INC. (US) | 2015-06-18 | — | — | WO | disclosed |
| WO-2015088565-A1 | P2X4 RECEPTOR MODULATING COMPOUNDS AND METHODS OF USE THEREOF | SUNOVION PHARMACEUTICALS INC. (US) | 2015-06-18 | — | — | WO | disclosed |